ATRACURIUM BESYLATE — all Canadian products
6 DINs
0 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ATRACURIUM BESYLATE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02240300 | ATRACURIUM - (FOR SINGLE DOSE ) | IVAX PHARMACEUTICALS INCORPORATED | Solution | Intravenous | ATRACURIUM BESYLATE 10 MG | Cancelled Pre Market | |
| 02240303 | ATRACURIUM - (FOR MULTIPLE DOSE VIAL - WITH PRESERVATIVE) | IVAX PHARMACEUTICALS INCORPORATED | Solution | Intravenous | ATRACURIUM BESYLATE 10 MG | Cancelled Pre Market | |
| 02229757 | ATRACURIUM BESYLATE INJECTION | ABBOTT LABORATORIES, LIMITED | Liquid | Intravenous | ATRACURIUM BESYLATE 10 MG | Cancelled Post Market | |
| 02236319 | ATRACURIUM BESYLATE INJECTION | HOSPIRA HEALTHCARE ULC | Solution | Intravenous | ATRACURIUM BESYLATE 10 MG | Cancelled Post Market | |
| 02236759 | ATRACURIUM BESYLATE INJECTION | SANDOZ CANADA INCORPORATED | Liquid | Intravenous | ATRACURIUM BESYLATE 10 MG | Cancelled Pre Market | |
| 00675210 | TRACRIUM | ABBVIE CORPORATION | Liquid | Intravenous | ATRACURIUM BESYLATE 10 MG | Cancelled Post Market |
Browse other molecules: